Coronary arterial lesions in survivors of cardiac transplantation result from accelerated coronary atherosclerosis. Clinical recognition of this event is difficult but essential for long-term management 
long-term survivor. 5 Over-all, survival in our series following transplantation is 43% at one year, 40% at two years and 26% at three years. If a patient survives the first three months following transplantation, his chance for living two years is 65%.f
As experience with these long-term survivors increased, we became aware of the development of coronary ischemia as a late complication.7 Patients have died in our series from 5 months to 43 months following transplantation as a result of progressive accelerated atherosclerosis causing obliteration of major coronary artery lumina. Since the transplanted heart is denervated, patients do not experience anginal symptoms, though they may develop arrhythmias, positive exercise tests, or other electrocardiographic evidence of myocardial ischemia. In an attempt to uncover evidence of coronary artery narrowing in a grafted heart, we began a systematic program of patient follow-up. Patient Studies Each patient is seen on a twice weekly basis for the first two months following discharge. Studies 8 Preformed catheters were introduced from the femoral artery. Minor modifications in the primary and secondary curves were necessary particularly to enter the right coronary ostium. Angulation at the aortic anastamosis due to a poor fit between a dilated recipient aorta and a normal sized donor aorta often resulted in a more anterior position of the right coronary ostium.9 Nevertheless, we were successful in selective catheterization in every case. There were no complications. Typical electrocardiographic changes were seen following injections into each coronary artery. of acute rejection episodes, the degree of specific lipoprotein abnormalities seen following transplantation, and the initial form of primary heart disease prior to transplantation.
The current immunosuppressant iegimen for the long-term transplant survivor includes prednisone 0.25 to 0.5 mg/kg and azathioprine 2 to 3 mg/kg. In addition, dipyridamole 100 mg q.i.d. and warfarin sodium have been used in all patients since September 1969 in an attempt to prevent platelet aggregation and microthromboses. All patients are on low cholesterol, high polyunsaturated fat diets as well as active exercise programs to improve over-all physical condition and maintain ideal body weight.
The normal arteriograms seen in our recent patients up to four years after transplantation show that accelerated atherosclerosis is not an inevitable finding in all patients following transplantation ( fig. 6 ). We believe that improved methods of early diagnosis and treatment of acute rejection episodes, rigid dietary and drug control of lipid abnormalities, as well as the use of dipyridamole and warfarin sodium, may be factors contributing to these improved results.
One further observation is worthy of mention. Coronary arteriography eight months after transplantation in one patient showed irregular luminal narrowings of the type usually associated with atherosclerosis. The patient has been maintained successfully on strict lipid control and the electrocardiogram and exercise tests have been normal. However, the donor heart had been obtained from a 42-year-old man. Because of the age of the donor, coronary arteriography had been performed prior to "death" and had demonstrated these same minor irregularities which did not compromise the lumen. There was no progression of disease over the eight month period of grafting. We now perform coronary arteriography routinely in prospective donors over the age of 35. Six of nine hearts studied for this reason were deemed unacceptable for transplantation because major abnormalities of the coronary arteries or left ventricular function were found.
Conclusion
Many important problems in the management of cardiac transplant patients are still unsolved. Therapy and prevention of the rejection phenomenon and control of opportunistic infections are examples. Coronary arteriography has proven to be a safe and useful technique for confirming and diagnosing graft atherosclerosis and for following serial changes in the coronary arteries of transplant patients. Current evidence indicates that coronary atherosclerosis may not be inevitable in the long-term transplant survivor if appropriate medical management and a careful dietary program are maintained.
